US · USD
CYTK
Cytokinetics Inc
- Day's range
- $60.68 – $62.53
- Day's volume
- $195.2M
- 52-week range
- $54.76 – $87.26
Follow CYTK in the Fuolio
See how CYTK weighs in your net worth, what it has paid you and how far it is from your target allocation.
Create a free accountCYTK in numbers
- Market cap
- $8.5B
- P/E
- -9.54
- P/B
- -49.16
- Dividend yield (12m)
- 0.00%
CYTK price history
CYTK risk and return
Monthly closes adjusted for splits and distributions.
| Metric | 12 months | 36 months | 60 months |
|---|---|---|---|
| Return | -9.95% | +83.24% | +55.95% |
| Volatility (annualized) | 30.65% | 98.58% | 80.54% |
| Largest drawdown | -27.98% | -62.85% | -62.85% |
| Positive months | 3/12 | 14/36 | 28/60 |
How much did investing in CYTK return?
$1,000.00 invested on 11/01/2021 would be worth $1,559.48 today.
- Value today in CYTK
- $1,559.48
- Return over the period
- +55.95%
- Return per year
- +9.44%
- In the S&P 500
- $1,712.05
With dividends reinvested, before taxes and costs, at month-end closes. Past returns do not guarantee future ones.
CYTK fundamentals
Valuation
- P/E-9.54
- P/B-49.16
- EV/EBITDA-12.29
- EV/EBIT-12.08
- EV/Revenue126.34
- P/EBIT-12.05
- P/S126.04
- P/OCF-15.36
- P/FCF-14.69
- Earnings yield-8.28%
- PEG ratio—
- Earnings per share-$6.43
- Book value per share-$1.25
Debt
- Net debt$20.3M
- Net debt/EBITDA—
- Net debt/Equity-0.12
- Debt/Equity-1.59
- Current ratio6.66
- Quick ratio6.66
- Cash ratio1.41
Efficiency
- Gross margin—
- EBITDA margin-1,027.58%
- Operating margin-1,046.12%
- Net margin-1,321.12%
- Asset turnover0.04
Profitability
- ROE515.31%
- ROA-46.45%
- ROIC—
- Payout—
Growth
- Revenue CAGR (5 years)3.20%
- Earnings CAGR (5 years)—
- Revenue growth (year)—
- Earnings growth (year)—
- Revenue growth (quarter)—
- Earnings growth (quarter)—
CYTK's indicators by year
Multiples at each year's closing price; margins and returns from that year's statements.
| Indicator | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| P/E | -9.97 | -9.45 | -16.34 | -11.21 | -17.96 | -11.61 | -5.18 | -3.26 |
| P/B | -11.86 | -41.15 | -22.26 | -40.41 | 15.86 | 13.03 | -57.67 | 13.38 |
| Earnings per share | -$6.37 | -$4.98 | -$5.11 | -$4.09 | -$2.54 | -$1.79 | -$2.05 | -$1.94 |
| Book value per share | -$5.36 | -$1.14 | -$3.75 | -$1.13 | $2.87 | $1.59 | -$0.18 | $0.47 |
| ROE | 119.00% | 435.49% | 136.22% | 360.48% | -88.29% | -112.27% | 1,112.66% | -409.84% |
| ROIC | — | — | — | — | -68.86% | -80.94% | — | -340.79% |
| EBITDA margin | -683.94% | -2,851.13% | -6,431.78% | -336.61% | -261.31% | -164.99% | -363.16% | -278.33% |
| Net margin | -891.60% | -3,191.11% | -6,988.63% | -411.21% | -305.72% | -228.00% | -452.93% | -337.41% |
CYTK's financial statements
| Line | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Net revenue | $88M | $18.5M | $7.5M | $94.6M | $70.4M | $55.8M |
| Cost of revenue | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| EBITDA | -$602.1M | -$526.7M | -$484.3M | -$318.4M | -$184M | -$92.1M |
| EBIT | -$612.3M | -$536.2M | -$496.2M | -$324.2M | -$186.3M | -$93.9M |
| Financial result | $48.4M | $51.5M | $27.6M | $11.3M | $331K | $5.3M |
| Income before tax | — | — | — | — | — | — |
| Income tax | -$0 | -$0 | -$0 | -$0 | -$0 | -$0 |
| Net income | -$785M | -$589.5M | -$526.2M | -$389M | -$215.3M | -$127.3M |
Figures the company filed with the CVM. Debt excludes leases; each quarter is that quarter alone.
Does CYTK pay dividends?
CYTK has no distributions on record.
About Cytokinetics
- Sector
- Manufacturing
Questions about CYTK
How much is CYTK today?
CYTK is at $61.35 (-2.15% on the day), last traded on 10/06/2026.
What are the P/E and P/B of CYTK?
CYTK trades at a P/E of -9.54 and a P/B of -49.16.
How much did CYTK return in 12 months?
CYTK returned -9.95% in 12 months, with annualized volatility of 30.65% and a largest drawdown of -27.98%.